序号 |
标题 |
次数 |
作者 |
发布时间 |
77446 |
Glcβ1-4[Glcβ1-4]3Glc-O-(CH2)3-NH2.HCl ,具有游离末端胺(接头-NH2 A)的纤维二糖 |
89 |
kx |
2024-12-13 |
77447 |
Glcβ1-4[Glcβ1-4]2Glc-O-(CH2)3-NH-DBCO ,含DBCO的纤维四糖(接头-DBCO A) |
127 |
kx |
2024-12-13 |
77448 |
DOTA-CH2-Ph-azide(HCl salt),DOTA螯合剂 |
124 |
h |
2024-12-13 |
77449 |
Glcβ1-4Glc-O-(CH2)3-NH-DBCO , 含DBCO的纤维二糖(接头-DBCO A) |
123 |
kx |
2024-12-13 |
77450 |
DOTA-DBCO双功能螯合剂 |
103 |
h |
2024-12-13 |
77451 |
Glcβ1-4Glcβ1-4Glc-O-(CH2)3-NH-DBCO , 含DBCO的纤维三糖(接头-DBCO A) |
111 |
kx |
2024-12-13 |
77452 |
DOTA-(COOt-Bu)3-NHS,CAS:819869-77-7 |
75 |
h |
2024-12-13 |
77453 |
GlcNAcβ1-3Gal与生物素和硬脂酸链相连(接头-BT-STEA A) |
100 |
kx |
2024-12-13 |
77454 |
棕榈酸-酮缩硫醇-羧酸,C16-TK-COOH |
106 |
wyh |
2024-12-13 |
77455 |
DOTA-(COOt-Bu)3-C2-NH2,CAS:173308-19-5 |
91 |
h |
2024-12-13 |
77456 |
Methyltetrazine-PEG5-CO-piperazine-C3-Mal的应用领域 |
98 |
kx |
2024-12-13 |
77457 |
DO-(CH2COOt-Bu)2,环状多胺多羧类配体,CAS:162148-48-3 |
111 |
h |
2024-12-13 |
77458 |
4,7,10-TRI-(T-BUTYLOXYCARBONYLMETHYL) |
74 |
h |
2024-12-13 |
77459 |
carboxymethyl-dextran-A2-gadolinium-DOTA |
84 |
h |
2024-12-13 |
77460 |
Tat-DOTA,DOTA-TAT(48-60),DOTA偶联细胞穿膜肽TAT |
147 |
h |
2024-12-13 |
77461 |
Cl-C6-PEG4-NHCO-C3-NHS,氯-C6--四聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
115 |
kx |
2024-12-13 |
77462 |
dysprosium-DOTA-PAMAM |
96 |
h |
2024-12-13 |
77463 |
Cl-C6-PEG3-NHCO-C3-NHS,氯-C6--三聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
142 |
kx |
2024-12-13 |
77464 |
Y-DOTA-TOC,CAS:293295-66-6 |
96 |
h |
2024-12-13 |
77465 |
DOTA-MAL-Cys39-exendin-4 |
130 |
h |
2024-12-13 |
77466 |
DO3A叔丁酯,CAS: 122555-91-3 |
281 |
h |
2024-12-13 |
77467 |
1202761-21-4,Biotinyl-NH-PEG3-C3-amido-C3-COOH |
125 |
kx |
2024-12-13 |
77468 |
(m-PEG4)2-C-C3-Br |
112 |
kx |
2024-12-13 |
77469 |
1,1,4,4,7,7-六(1,1-二甲基乙基)10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸酯 |
175 |
h |
2024-12-13 |
77470 |
二乙酰氧二辛基锡盐,CAS:17586-94-6 |
135 |
h |
2024-12-13 |
77471 |
二苯基环辛炔-聚乙二醇-大环配体 |
103 |
h |
2024-12-13 |
77472 |
Azide-PEG11-CH2CH2CH2-COOtBu,叠氮-十一聚乙二醇-C3-叔丁酯 |
122 |
kx |
2024-12-13 |
77473 |
(S)-4-(4-(3-((4-((2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL) |
139 |
h |
2024-12-13 |
77474 |
DOTA四乙酸酯,CAS: 825625-07-8 |
211 |
h |
2024-12-13 |
77475 |
Boc-NH-PEG7-C3-acid,氨基叔丁酯-七聚乙二醇-C3-酸 |
89 |
kx |
2024-12-13 |
77476 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
114 |
h |
2024-12-13 |
77477 |
2731015-03-3,Boc-NH-PEG1-C3-acid,氨基叔丁酯-一聚乙二醇-C3-酸 |
112 |
kx |
2024-12-13 |
77478 |
Azide-PEG6-CH2CH2CH2-COOtBu,叠氮-六聚乙二醇-C3-叔丁酯 |
89 |
kx |
2024-12-13 |
77479 |
APN-C3-PEG5-acid, APN-C3-五聚乙二醇-羧酸 |
90 |
kx |
2024-12-13 |
77480 |
Pomalidomide-C3-NH2 hydrochloride的主要结构与功能基团 |
111 |
kx |
2024-12-13 |
77481 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl)ester,(αR)- |
123 |
h |
2024-12-13 |
77482 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
88 |
h |
2024-12-13 |
77483 |
Azide-C3-Iodoacetamide的应用领域 |
86 |
kx |
2024-12-13 |
77484 |
CAS: 1161883-51-7,Propargyl-PEG5-CH2CO2-NHS |
125 |
WYQ |
2024-12-13 |
77485 |
CAS: 1429934-37-1,Propargyl-PEG5-CH2CO2H |
92 |
WYQ |
2024-12-13 |
77486 |
CAS:1610950-41-8,DOTA-甲基四嗪 |
90 |
h |
2024-12-13 |
77487 |
CAS: 1694731-93-5,Propargyl-PEG4-CH2CO2H |
74 |
WYQ |
2024-12-13 |
77488 |
CAS: 141282-35-1,Amino-PEG5-CH2CO2H(氨基-五聚乙二醇-乙酸) |
92 |
WYQ |
2024-12-13 |
77489 |
2768332-86-9,FmocNH-C2-NHCO-PC-NHCO-C4-COOH,N-芴甲氧羰基-C2-酰胺-PC-酰胺-C4-羧酸 |
82 |
kx |
2024-12-13 |
77490 |
CAS:1345034-50-5,DOTA-(COOt-Bu)3 |
84 |
h |
2024-12-13 |